Medical isotope production without highly enriched uranium:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
c2009
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Title from electronic title page (viewed June 1, 2009) "This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply." Includes bibliographical references Background and study task -- Molybdenum-99/Technetium-99m production and use -- Molybdenum-99/Technetium-99m supply -- Molybdenum-99/Technetium-99m supply reliability -- Molybdenum-99/Technetium-99m demand -- Molybdenum-99/Technetium-99m production costs -- Conversion to LEU-based production of Molybdenum-99: technical considerations -- Conversion to LEU-based production of Molybdenum-99: regulatory considerations -- Conversion to LEU-based production of Molybdenum-99: general approaches and timing -- Conversion to LEU-based production of Molybdenum-99: prospects and feasibility |
| Beschreibung: | 1 Online-Ressource (xviii, 202 p.) |
| ISBN: | 0309130409 9780309130400 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043141406 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2009 |||| o||u| ||||||eng d | ||
| 020 | |a 0309130409 |c electronic bk. |9 0-309-13040-9 | ||
| 020 | |a 9780309130400 |c electronic bk. |9 978-0-309-13040-0 | ||
| 035 | |a (OCoLC)367597412 | ||
| 035 | |a (DE-599)BVBBV043141406 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 353.008722 |2 22 | |
| 245 | 1 | 0 | |a Medical isotope production without highly enriched uranium |c Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c c2009 | |
| 300 | |a 1 Online-Ressource (xviii, 202 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from electronic title page (viewed June 1, 2009) | ||
| 500 | |a "This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply." | ||
| 500 | |a Includes bibliographical references | ||
| 500 | |a Background and study task -- Molybdenum-99/Technetium-99m production and use -- Molybdenum-99/Technetium-99m supply -- Molybdenum-99/Technetium-99m supply reliability -- Molybdenum-99/Technetium-99m demand -- Molybdenum-99/Technetium-99m production costs -- Conversion to LEU-based production of Molybdenum-99: technical considerations -- Conversion to LEU-based production of Molybdenum-99: regulatory considerations -- Conversion to LEU-based production of Molybdenum-99: general approaches and timing -- Conversion to LEU-based production of Molybdenum-99: prospects and feasibility | ||
| 650 | 7 | |a POLITICAL SCIENCE / Public Affairs & Administration |2 bisacsh | |
| 650 | 4 | |a Molybdenum / supply & distribution / United States | |
| 650 | 4 | |a Nuclear Medicine / standards / United States | |
| 650 | 4 | |a Molybedenum / isolation & purification / United States | |
| 650 | 4 | |a Radioisotopes / supply & distribution / United States | |
| 650 | 4 | |a Technetium Compounds / isolation & purification / United States | |
| 650 | 4 | |a Diagnostic Imaging / United States | |
| 650 | 4 | |a Radionuclide Generators / United States | |
| 650 | 4 | |a Quality Control / United States | |
| 650 | 4 | |a Uranium |x Isotopes | |
| 650 | 4 | |a Uranium |x Isotopes |x Therapeutic use | |
| 650 | 4 | |a Highly enriched uranium |x Isotopes |x Therapeutic use | |
| 650 | 4 | |a Molybdenum |x Isotopes |x Therapeutic use | |
| 650 | 4 | |a Technetium |x Isotopes |x Therapeutic use | |
| 650 | 4 | |a Radioisotopes |x Therapeutic use | |
| 650 | 4 | |a Nuclear medicine |x Standards |z United States | |
| 651 | 4 | |a USA | |
| 710 | 2 | |a National Research Council (U.S.) |b Committee on Medical Isotope Production Without Highly Enriched Uranium |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 0-309-13039-5 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 978-0-309-13039-4 |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=285289 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028565597 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=285289 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=285289 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175590942572544 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043141406 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)367597412 (DE-599)BVBBV043141406 |
| dewey-full | 353.008722 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 353 - Specific fields of public administration |
| dewey-raw | 353.008722 |
| dewey-search | 353.008722 |
| dewey-sort | 3353.008722 |
| dewey-tens | 350 - Public administration and military science |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04437nmm a2200601zc 4500</leader><controlfield tag="001">BV043141406</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2009 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309130409</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-13040-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309130400</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-13040-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)367597412</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043141406</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">353.008722</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Medical isotope production without highly enriched uranium</subfield><subfield code="c">Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xviii, 202 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from electronic title page (viewed June 1, 2009)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply."</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Background and study task -- Molybdenum-99/Technetium-99m production and use -- Molybdenum-99/Technetium-99m supply -- Molybdenum-99/Technetium-99m supply reliability -- Molybdenum-99/Technetium-99m demand -- Molybdenum-99/Technetium-99m production costs -- Conversion to LEU-based production of Molybdenum-99: technical considerations -- Conversion to LEU-based production of Molybdenum-99: regulatory considerations -- Conversion to LEU-based production of Molybdenum-99: general approaches and timing -- Conversion to LEU-based production of Molybdenum-99: prospects and feasibility</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">POLITICAL SCIENCE / Public Affairs & Administration</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molybdenum / supply & distribution / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear Medicine / standards / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molybedenum / isolation & purification / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radioisotopes / supply & distribution / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technetium Compounds / isolation & purification / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diagnostic Imaging / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radionuclide Generators / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quality Control / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Uranium</subfield><subfield code="x">Isotopes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Uranium</subfield><subfield code="x">Isotopes</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Highly enriched uranium</subfield><subfield code="x">Isotopes</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molybdenum</subfield><subfield code="x">Isotopes</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technetium</subfield><subfield code="x">Isotopes</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radioisotopes</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear medicine</subfield><subfield code="x">Standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Research Council (U.S.)</subfield><subfield code="b">Committee on Medical Isotope Production Without Highly Enriched Uranium</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">0-309-13039-5</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">978-0-309-13039-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=285289</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028565597</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=285289</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=285289</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043141406 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:18:43Z |
| institution | BVB |
| isbn | 0309130409 9780309130400 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028565597 |
| oclc_num | 367597412 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xviii, 202 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Medical isotope production without highly enriched uranium Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies Washington, D.C. National Academies Press c2009 1 Online-Ressource (xviii, 202 p.) txt rdacontent c rdamedia cr rdacarrier Title from electronic title page (viewed June 1, 2009) "This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply." Includes bibliographical references Background and study task -- Molybdenum-99/Technetium-99m production and use -- Molybdenum-99/Technetium-99m supply -- Molybdenum-99/Technetium-99m supply reliability -- Molybdenum-99/Technetium-99m demand -- Molybdenum-99/Technetium-99m production costs -- Conversion to LEU-based production of Molybdenum-99: technical considerations -- Conversion to LEU-based production of Molybdenum-99: regulatory considerations -- Conversion to LEU-based production of Molybdenum-99: general approaches and timing -- Conversion to LEU-based production of Molybdenum-99: prospects and feasibility POLITICAL SCIENCE / Public Affairs & Administration bisacsh Molybdenum / supply & distribution / United States Nuclear Medicine / standards / United States Molybedenum / isolation & purification / United States Radioisotopes / supply & distribution / United States Technetium Compounds / isolation & purification / United States Diagnostic Imaging / United States Radionuclide Generators / United States Quality Control / United States Uranium Isotopes Uranium Isotopes Therapeutic use Highly enriched uranium Isotopes Therapeutic use Molybdenum Isotopes Therapeutic use Technetium Isotopes Therapeutic use Radioisotopes Therapeutic use Nuclear medicine Standards United States USA National Research Council (U.S.) Committee on Medical Isotope Production Without Highly Enriched Uranium Sonstige oth Erscheint auch als Druck-Ausgabe, Paperback 0-309-13039-5 Erscheint auch als Druck-Ausgabe, Paperback 978-0-309-13039-4 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=285289 Aggregator Volltext |
| spellingShingle | Medical isotope production without highly enriched uranium POLITICAL SCIENCE / Public Affairs & Administration bisacsh Molybdenum / supply & distribution / United States Nuclear Medicine / standards / United States Molybedenum / isolation & purification / United States Radioisotopes / supply & distribution / United States Technetium Compounds / isolation & purification / United States Diagnostic Imaging / United States Radionuclide Generators / United States Quality Control / United States Uranium Isotopes Uranium Isotopes Therapeutic use Highly enriched uranium Isotopes Therapeutic use Molybdenum Isotopes Therapeutic use Technetium Isotopes Therapeutic use Radioisotopes Therapeutic use Nuclear medicine Standards United States |
| title | Medical isotope production without highly enriched uranium |
| title_auth | Medical isotope production without highly enriched uranium |
| title_exact_search | Medical isotope production without highly enriched uranium |
| title_full | Medical isotope production without highly enriched uranium Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies |
| title_fullStr | Medical isotope production without highly enriched uranium Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies |
| title_full_unstemmed | Medical isotope production without highly enriched uranium Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies |
| title_short | Medical isotope production without highly enriched uranium |
| title_sort | medical isotope production without highly enriched uranium |
| topic | POLITICAL SCIENCE / Public Affairs & Administration bisacsh Molybdenum / supply & distribution / United States Nuclear Medicine / standards / United States Molybedenum / isolation & purification / United States Radioisotopes / supply & distribution / United States Technetium Compounds / isolation & purification / United States Diagnostic Imaging / United States Radionuclide Generators / United States Quality Control / United States Uranium Isotopes Uranium Isotopes Therapeutic use Highly enriched uranium Isotopes Therapeutic use Molybdenum Isotopes Therapeutic use Technetium Isotopes Therapeutic use Radioisotopes Therapeutic use Nuclear medicine Standards United States |
| topic_facet | POLITICAL SCIENCE / Public Affairs & Administration Molybdenum / supply & distribution / United States Nuclear Medicine / standards / United States Molybedenum / isolation & purification / United States Radioisotopes / supply & distribution / United States Technetium Compounds / isolation & purification / United States Diagnostic Imaging / United States Radionuclide Generators / United States Quality Control / United States Uranium Isotopes Uranium Isotopes Therapeutic use Highly enriched uranium Isotopes Therapeutic use Molybdenum Isotopes Therapeutic use Technetium Isotopes Therapeutic use Radioisotopes Therapeutic use Nuclear medicine Standards United States USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=285289 |
| work_keys_str_mv | AT nationalresearchcounciluscommitteeonmedicalisotopeproductionwithouthighlyenricheduranium medicalisotopeproductionwithouthighlyenricheduranium |